BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17267315)

  • 1. Immunohistochemical analysis of pro-apoptotic PUMA protein and mutational analysis of PUMA gene in gastric carcinomas.
    Yoo NJ; Lee JW; Jeong EG; Lee SH
    Dig Liver Dis; 2007 Mar; 39(3):222-7. PubMed ID: 17267315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and expressional analysis of BNIP3, a pro-apoptotic Bcl-2 member, in gastric carcinomas.
    Lee SH; Jeong EG; Yoo NJ; Lee SH
    APMIS; 2007 Nov; 115(11):1274-80. PubMed ID: 18092960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of phospho-BAD protein and mutational analysis of BAD gene in gastric carcinomas.
    Jeong EG; Lee SH; Kim SS; Ahn CH; Yoo NJ; Lee SH
    APMIS; 2007 Aug; 115(8):976-81. PubMed ID: 17696955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical and mutational analysis of FLASH in gastric carcinomas.
    Jeong EG; Lee SH; Lee HW; Soung YH; Yoo NJ; Lee SH
    APMIS; 2007 Aug; 115(8):900-5. PubMed ID: 17696945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas.
    Kim MR; Jeong EG; Chae B; Lee JW; Soung YH; Nam SW; Lee JY; Yoo NJ; Lee SH
    Dig Dis Sci; 2007 Oct; 52(10):2751-6. PubMed ID: 17393317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas.
    Lee JW; Jeong EG; Soung YH; Nam SW; Lee JY; Yoo NJ; Lee SH
    Pathology; 2006 Aug; 38(4):312-5. PubMed ID: 16916719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway.
    Concannon CG; Koehler BF; Reimertz C; Murphy BM; Bonner C; Thurow N; Ward MW; Villunger A; Strasser A; Kögel D; Prehn JH
    Oncogene; 2007 Mar; 26(12):1681-92. PubMed ID: 16983338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expressional analysis of anti-apoptotic phospho-BAD protein and mutational analysis of pro-apoptotic BAD gene in hepatocellular carcinomas.
    Yoo NJ; Lee JW; Jeong EG; Soung YH; Nam SW; Lee JY; Lee SH
    Dig Liver Dis; 2006 Sep; 38(9):683-7. PubMed ID: 16807152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
    Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
    J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivating mutation of the pro-apoptotic gene BID in gastric cancer.
    Lee JH; Soung YH; Lee JW; Park WS; Kim SY; Cho YG; Kim CJ; Seo SH; Kim HS; Nam SW; Yoo NJ; Lee SH; Lee JY
    J Pathol; 2004 Apr; 202(4):439-45. PubMed ID: 15095271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA and protein expression of PUMA in sporadic colorectal cancer.
    Jansson A; Arbman G; Sun XF
    Oncol Rep; 2004 Dec; 12(6):1245-9. PubMed ID: 15547745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and mutational analysis of apoptosis-inducing factor (AIF) in colorectal carcinomas.
    Jeong EG; Lee JW; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2006 Dec; 114(12):867-73. PubMed ID: 17207087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in mice.
    Chen S; Zheng J; Hao Q; Yang S; Wang J; Chen H; Chen L; Zhou Y; Yu C; Jiao B; Cai Z
    J Hepatol; 2010 Jun; 52(6):864-71. PubMed ID: 20413175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas.
    Soung YH; Lee JW; Kim SY; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH
    APMIS; 2006 Apr; 114(4):292-7. PubMed ID: 16689829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical model of a network of interaction between p53 and Bcl-2 during genotoxic-induced apoptosis.
    Dogu Y; Díaz J
    Biophys Chem; 2009 Jul; 143(1-2):44-54. PubMed ID: 19395147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells.
    Liu HF; Hsiao PW; Chao JI
    Chem Biol Interact; 2008 Oct; 176(1):48-57. PubMed ID: 18760266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expressional and mutational analysis of pro-apoptotic Bcl-2 member PUMA in hepatocellular carcinomas.
    Ahn CH; Jeong EG; Kim SS; Lee JW; Lee SH; Kim SH; Kim MS; Yoo NJ; Lee SH
    Dig Dis Sci; 2008 May; 53(5):1395-9. PubMed ID: 17934815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.